# A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer

> **NCT01050985** · PHASE1 · COMPLETED · sponsor: **Georgetown University** · enrollment: 47 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** Temsirolimus and capecitabine

## Key facts

- **NCT ID:** NCT01050985
- **Lead sponsor:** Georgetown University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2013-03
- **Final completion:** 2013-06
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01050985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01050985, "A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01050985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*